<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659111424637</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659111424637</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Plasma levels of potassium and magnessium after modified ultrafiltration in pediatric cardiac surgery with cardiopulmonary bypass</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>López</surname><given-names>R</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lema</surname><given-names>G</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>González</surname><given-names>A</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carvajal</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Canessa</surname><given-names>R</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carrasco</surname><given-names>P</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lazo</surname><given-names>V</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hudson</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-0267659111424637">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gonzalez</surname><given-names>R</given-names></name>
<xref ref-type="aff" rid="aff2-0267659111424637">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Frangini</surname><given-names>P</given-names></name>
<xref ref-type="aff" rid="aff3-0267659111424637">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0267659111424637"><label>1</label>Division of Anesthesiology, Pontificia Universidad Católica de Chile, Santiago, Chile</aff>
<aff id="aff2-0267659111424637"><label>2</label>Division of Cardiovascular Diseases, Pontificia Universidad Católica de Chile, Santiago, Chile</aff>
<aff id="aff3-0267659111424637"><label>3</label>Division of Pediatrics, Pontificia Universidad Católica de Chile, Santiago, Chile</aff>
<author-notes>
<corresp id="corresp1-0267659111424637">Rodrigo López, Division of Anesthesiology, Facultad de Medicina, Pontificia Universidad Católica de Chile Marcoleta 367 Santiago Chile Email: <email>ralopez@puc.cl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>42</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective:</italic> Modified ultrafiltration (MUF) reduces some of the complications associated with cardiopulmonary bypass (CPB) in pediatric cardiac surgery. However, we have observed hypokalemia and hypomagnesemia in children when MUF is used. Such alterations may elicit severe arrhythmias in the postoperative period. To date, no studies have focused on the effects MUF may have in plasma levels of potassium (K) and magnesium (Mg). The objective of our study was to determine if there is any variation in plasma levels of K (plK) and Mg (plMg) after MUF in children undergoing cardiac surgery with CPB.</p>
<p><italic>Patients:</italic> Sixteen children scheduled for cardiac surgery with CBP and MUF were prospectively studied. Anesthetic, CPB and MUF management were standardized for all patients, the latter lasting for 10 minutes.</p>
<p><italic>Results:</italic> Plasma K average levels before and after MUF were 4.16 mmol/L and 3.58 mmol/L, respectively. The average plasma Mg levels before and after MUF were 4.82 mmol/L and 4.81 mmol/L, respectively.</p>
<p><italic>Conclusions:</italic> The plasma level of K is reduced by 13.7% after MUF (p&lt;0.0001). The reduction in Mg at the same period of time was not statistically significant (p&lt;0.970).</p>
</abstract>
<kwd-group>
<kwd>ediatric cardiac surgery</kwd>
<kwd>modified ultrafiltration</kwd>
<kwd>cardiopulmonary bypass</kwd>
<kwd>electrolytes</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0267659111424637" sec-type="intro">
<title>Introduction</title>
<p>Surgery for congenital heart defects carries morbidity and mortality, especially for more susceptible patients, such as newborns, low weight and undernourished children. Anesthesia, surgery and CPB impose severe challenges to them.</p>
<p>During CPB, many organs are subjected to suffer from mild to severe dysfunction due to physiological alterations inherent to this technique. Blood is under contact with foreign surfaces, activating a series of inflammatory reactions that induce changes in capillary permeability. Furthermore, the hemodilution caused by CPB lowers the osmotic pressure, resulting in edema that may compromise the normal functioning of many organs<sup><xref ref-type="bibr" rid="bibr1-0267659111424637">1</xref>-<xref ref-type="bibr" rid="bibr3-0267659111424637">3</xref></sup>.</p>
<p>Romagnoli introduced ultrafiltration to CPB. However, it was Magilligan who popularized this technique in cardiac surgery, mainly to remove the excess water associated with hemodilution<sup><xref ref-type="bibr" rid="bibr1-0267659111424637">1</xref></sup>. Later, Naik et al. introduced modified ultrafiltration (MUF) in 1991<sup><xref ref-type="bibr" rid="bibr2-0267659111424637">2</xref></sup>. This procedure reduces excess water, increasing osmotic pressure, hematocrit, systemic blood pressure and cardiac output. Clinically, the technique decreases the use of inotropic drugs in the post-operative period and improves the systolic and diastolic function of the left ventricle. Moreover, as solutes smaller than 65,000 Daltons are removed by ultrafitration<sup><xref ref-type="bibr" rid="bibr4-0267659111424637">4</xref></sup>, it has been demonstrated to clear some inflammatory mediators<sup><xref ref-type="bibr" rid="bibr5-0267659111424637">5</xref>,<xref ref-type="bibr" rid="bibr6-0267659111424637">6</xref></sup>. The benefits of this technique are more significant in children, being considered nowadays as suitable for most pediatric cardiac surgery with CPB.</p>
<p>Despite its many advantages, there are certain risks associated with the use of MUF, such as air intake in the aortic cannula and hemodynamic instability, among others<sup><xref ref-type="bibr" rid="bibr7-0267659111424637">7</xref></sup>. A high ultrafiltrate flow rate may also diminish cerebral blood flow, decreasing the cerebral mixed venous oxygen saturation<sup><xref ref-type="bibr" rid="bibr8-0267659111424637">8</xref></sup>.</p>
<p>Alterations in the hydroelectrolytic balance may induce the appearance of arrhythmias in the early post-operative period that increase morbidity and mortality<sup><xref ref-type="bibr" rid="bibr9-0267659111424637">9</xref></sup>. We have observed hypokalemias and hypomagnesemias, requiring treatment in children when MUF is used. These changes could be explained by the proven ability ultrafiltration has to clear small solutes from the blood<sup><xref ref-type="bibr" rid="bibr4-0267659111424637">4</xref></sup>. However, to our knowledge, there are no studies regarding the effects that MUF can have in the immediate hydroelectrolytic balance, specifically potassium and magnesium.</p>
<p>The main objective of the present study is to determine if there is any variation in plasma levels of K (plK) and Mg (plMg) in children undergoing cardiac surgery after MUF.</p>
</sec>
<sec id="section2-0267659111424637" sec-type="materials|methods">
<title>Material and Method</title>
<p>After Institutional Review Board approval and signed informed consent by the parents, 16 children were prospectively studied in a single center. All of them were scheduled for cardiac surgery with CPB. In our centre, we perform MUF in children under 15 kg, making this weight one of the inclusion criteria. Demographic characteristics are shown in <xref ref-type="table" rid="table1-0267659111424637">Table 1</xref>. Exclusion criterion was renal insufficiency, acute or chronic. Anesthetic management was standardized, using isofluorane and fentanyl. Patients were monitored with a five-derivation ECG and ST analysis, invasive blood pressure monitoring, central venous pressure, pulse oximetry, capnography, arterial blood gas analysis, rectal and nasopharyngeal temperatures and hourly diuresis. Systemic anticoagulation was achieved with heparin 300 IU/kg for an activated clotting time (ACT) of more than 480 seconds. Crystalloid cardioplegia was used in all patients. The CPB was conducted with a roller pump and a microporous membrane oxygenator (Baby RX, Terumo, Santiago, Chile). Cardiac index was maintained between 2.4 and 2.8 L/min/m<sup>2</sup>. Sanguineous prime solution was used. The oxygenator prime included: mannitol 0.5 g/kg, packed red blood cells (with heparin 300 IU every 500ml), furosemide 0.25mg/kg and albumin 5g, to achieve an hematocrit of 30%. MUF began once CPB concluded. The flow of the hemofilter (Terumo CX*HC05S) was kept at 10-15 ml/kg/min, with a negative pressure of 125mmHg. The standarized duration of MUF in our center is 10 minutes in all patients. Blood samples were taken from the venous line before and after MUF to measure plK and plMg. None of the patients received supplements of K or Mg. The software used for statistical analysis was Minitab 15. The comparison between the levels of K and Mg before and after MUF was done with a t-test for paired samples.</p>
<table-wrap id="table1-0267659111424637" position="float">
<label>Table 1.</label>
<caption><p>Demographic data and CPB timing</p></caption>
<graphic alternate-form-of="table1-0267659111424637" xlink:href="10.1177_0267659111424637-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="left">Mean (± SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (months)</td>
<td>4.08 (2.74)</td>
</tr>
<tr>
<td>Weight (kg)</td>
<td>4.72 (1.39)</td>
</tr>
<tr>
<td>Height (cm)</td>
<td>58.16 (6.54)</td>
</tr>
<tr>
<td>Body Surface Area</td>
<td>0.27 (0.06)</td>
</tr>
<tr>
<td>CPB time (min)</td>
<td>141.94 (52.26)</td>
</tr>
<tr>
<td>Aortic clamp time (min)</td>
<td>76.62 (23.58)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0267659111424637">
<p>SD: standard deviation; CPB: cardiopulmonary bypass</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section3-0267659111424637" sec-type="results">
<title>Results</title>
<p>The surgical data are shown in <xref ref-type="table" rid="table1-0267659111424637">Table 1</xref>. The main surgeries were atriovenous (AV) canal (43.8%) and ventricular septal defect (VSD) (37.5%).</p>
<p>The values of the averages pre-MUF and post-MUF for plK and plMg are shown in <xref ref-type="table" rid="table2-0267659111424637">Table 2</xref>. The only statistically significant difference was between plK pre-MUF and post-MUF (p&lt;0.0001).</p>
<table-wrap id="table2-0267659111424637" position="float">
<label>Table 2</label>
<caption><p>Plasma levels of K and Mg</p></caption>
<graphic alternate-form-of="table2-0267659111424637" xlink:href="10.1177_0267659111424637-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="left">Mean (± SD)</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>K pre-MUF (mmol/L)</td>
<td>4.16 (0.53)</td>
<td>&lt;0.05</td>
</tr>
<tr>
<td>K post-MUF (mmol/L)</td>
<td>3.58 (0.52)</td>
<td/>
</tr>
<tr>
<td>Mg pre-MUF (mmol/L)</td>
<td>4.82 (1.39)</td>
<td>0.97</td>
</tr>
<tr>
<td>Mg post-MUF (mmol/L)</td>
<td>4.81 (0.87)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0267659111424637">
<p>SD: standard deviation</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-0267659111424637" sec-type="discussion">
<title>Discussion</title>
<p>In our study, we found a reduction in plK after MUF of 13.7% (p&lt;0.0001). Plasma levels of magnesium do not change significantly after MUF.</p>
<p>There are many variables that may be involved in extracellular potassium regulation, such as acid-base state, sympathetic activity, insulin, urine output, previous diuretic therapy, vasoactive drugs and blood transfusions<sup><xref ref-type="bibr" rid="bibr10-0267659111424637">10</xref></sup>. Since this is a single-center study, anesthesia care, CPB technique and surgical interventions are fairly uniform. Therefore, we may assume that most of these confounding variables were homogenous. As ultrafiltration has the proven ability of clearing small solutes from the blood<sup><xref ref-type="bibr" rid="bibr4-0267659111424637">4</xref></sup>, these changes in plK found in this study could be related to MUF. However, it is not possible to conclude that the reduction in plK is caused only by this technique.</p>
<p>Despite the major role plK has in the maintenance of the resting membrane potential and, thus, in the regulation of the excitatory and conductive system of the heart, literature about its regulation on CPB is insufficient. Outhauls et al. showed a reduction in plK from 4.0 mmol/L at the beginning of surgery to 3.4 mmol/L during CPB<sup><xref ref-type="bibr" rid="bibr11-0267659111424637">11</xref></sup>. The design of their study, however, was somewhat different from ours. In their protocol, the priming solution was filtered before and throughout CPB. All patients required potassium administration at the end of bypass to reach high normal serum levels.</p>
<p>To our knowledge, this is the first study showing a decrease in plK immediately after MUF in children undergoing cardiac surgery with CPB. Based on these findings, it is possible to suggest that supplementation with K in patients with low levels of plK pre-MUF could prevent even lower levels of plK post-MUF.</p>
    <p>In regard to plMg, there are studies suggesting the benefits of administering magnesium after pediatric cardiac surgery in order to prevent junctional arrhythmias<sup><xref ref-type="bibr" rid="bibr12-0267659111424637">12</xref>,<xref ref-type="bibr" rid="bibr13-0267659111424637">13</xref></sup>. Dorman et al. showed a reduction in junctional ectopic tachycardia from 27% of children to 0% after the administration of 30mg/kg of magnesium<sup><xref ref-type="bibr" rid="bibr12-0267659111424637">12</xref></sup>. Manrique et al. obtained similar results: there was a reduction in the incidence of this rhythm abnormality from 17.9% to 6.7% when administering 25mg/kg of magnesium; and no cases in the group receiving 50mg/kg<sup><xref ref-type="bibr" rid="bibr13-0267659111424637">13</xref></sup>. Despite the literature supporting this supplementation, there is scarce information about plMg changes related to CPB. The non-significant reduction of this electrolyte after MUF could be related to the fact that many patients arrive at the operating room with chronic deprivation of Mg, due to long-lasting diuretic therapy or in a condition of undernourishment<sup><xref ref-type="bibr" rid="bibr13-0267659111424637">13</xref>,<xref ref-type="bibr" rid="bibr14-0267659111424637">14</xref></sup>. The hemodilution caused by the priming solution worsens this situation. Our results show that MUF does not have a major impact on plMg, making the chronic deprivation of Mg a very possible explanation. Since not all patients have low levels of plMg before MUF, routine administration should not be encouraged.</p>
<p>Our study has some limitations. The sample size was not strong enough to demonstrate the influences of other variables interfering with the extracellular potassium concentration, nor to search for arrhythmias as a clinical outcome. There are many factors influencing the hydroelectrolytic balance after CPB, such as inotropic usage, prime composition, acid-base alterations, and blood transfusions, among others. Our study was designed exclusively to observe variations of plK and plMg after MUF. In this context, our results suggest that MUF could be another factor influencing plK and plMg after CPB. Whether these findings have implications in therapy or major postoperative outcomes such as arrhythmias are just speculative.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
<fn fn-type="conflict">
<p>The authors declare that there is no conflict of interest</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659111424637">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elliott</surname><given-names>M</given-names></name>
</person-group>. <article-title>Modified ultrafiltration and open-heart surgery in children</article-title>. <source>Paediatric Anaesthesia</source> <year>1999</year>; <volume>9</volume>: <fpage>1</fpage>–<lpage>5</lpage></citation>
</ref>
<ref id="bibr2-0267659111424637">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Naik</surname><given-names>S</given-names></name>
<name><surname>Knight</surname><given-names>A</given-names></name>
<name><surname>Elliott</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>A successful modification of ultrafiltration for cardiopulmonary bypass in children</article-title>. <source>Perfusion</source> <year>1991</year>; <volume>6</volume>: <fpage>41</fpage>–<lpage>50</lpage></citation>
</ref>
<ref id="bibr3-0267659111424637">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aggarwal</surname><given-names>N</given-names></name>
<name><surname>Das</surname><given-names>S</given-names></name>
<name><surname>Sharma</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy of combined modified and conventional ultrafiltration during cardiac surgery in children</article-title>. <source>Ann Cardiac Anaesth</source> <year>2007</year>; <volume>10</volume>: <fpage>27</fpage>–<lpage>33</lpage></citation>
</ref>
<ref id="bibr4-0267659111424637">
<label>4.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Sutton</surname><given-names>R</given-names></name>
<name><surname>Rothernberg</surname><given-names>D</given-names></name>
</person-group>. <article-title>Ultrafiltration and dialysis</article-title>. In: <person-group person-group-type="editor">
<name><surname>Gravlee</surname><given-names>G</given-names></name>
<name><surname>Davis</surname><given-names>RF</given-names></name>
<name><surname>Stammers</surname><given-names>AH</given-names></name>
<name><surname>Ungerleider</surname><given-names>RM</given-names></name>
</person-group>. (eds), <source>Cardiopulmonary Bypass: Principles and Practice</source> <edition>3rd ed.</edition> <publisher-loc>Philadelphia, PN</publisher-loc>: <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>, <year>2008</year>, pp <fpage>116</fpage></citation>
</ref>
<ref id="bibr5-0267659111424637">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sever</surname><given-names>K</given-names></name>
<name><surname>Tansel</surname><given-names>T</given-names></name>
<name><surname>Basaran</surname><given-names>M</given-names></name>
</person-group>. <article-title>The benefits of continuous ultrafiltration in pediatric cardiac surgery</article-title>. <source>Scand Cardiovasc J</source> <year>2004</year>; <volume>38</volume>: <fpage>307</fpage>–<lpage>311</lpage></citation>
</ref>
<ref id="bibr6-0267659111424637">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bando</surname><given-names>K</given-names></name>
<name><surname>Turrentine</surname><given-names>M</given-names></name>
<name><surname>Vijay</surname><given-names>P</given-names></name>
</person-group>. <article-title>Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease</article-title>. <source>Ann Thorac Surg</source> <year>1998</year>; <volume>66</volume>: <fpage>821</fpage>–<lpage>827</lpage></citation>
</ref>
<ref id="bibr7-0267659111424637">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>G</given-names></name>
<name><surname>Ramamoorthy</surname><given-names>C</given-names></name>
<name><surname>Chu</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Modified and conventional ultrafiltration during pediatric cardiac surgery: clinical outcomes compared</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>2006</year>; <volume>132</volume>: <fpage>1291</fpage>–<lpage>1298</lpage></citation>
</ref>
<ref id="bibr8-0267659111424637">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodriguez</surname><given-names>R</given-names></name>
<name><surname>Ruel</surname><given-names>M</given-names></name>
<name><surname>Broecker</surname><given-names>L</given-names></name>
<name><surname>Cornel</surname><given-names>G</given-names></name>
</person-group>. <article-title>High flow rates during modified ultrafiltration decrease cerebral blood flow velocity and venous oxygen saturation in infants</article-title>. <source>Ann Thorac Surg</source> <year>2005</year>; <volume>80</volume>: <fpage>22</fpage>–<lpage>28</lpage></citation>
</ref>
<ref id="bibr9-0267659111424637">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Delaney</surname><given-names>J</given-names></name>
<name><surname>Moltedo</surname><given-names>J</given-names></name>
<name><surname>Dziura</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Early postoperative arrhythmias after pediatric cardiac surgery</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>2006</year>; <volume>131</volume>: <fpage>1296</fpage>–<lpage>1301</lpage></citation>
</ref>
<ref id="bibr10-0267659111424637">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Guyton</surname><given-names>A</given-names></name>
<name><surname>Hall</surname><given-names>J</given-names></name>
</person-group>. <article-title>Rhythmical excitation of the heart</article-title>. In: <source>Textbook of medical physiology</source>. <publisher-loc>Philadelphia, PN</publisher-loc>: <publisher-name>Elsevier Saunder</publisher-name>, <year>2006</year>, pp <fpage>116</fpage>–<lpage>122</lpage></citation>
</ref>
<ref id="bibr11-0267659111424637">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>WA Osthaus</surname><given-names>WA</given-names></name>
<name><surname>Görler</surname><given-names>H</given-names></name>
<name><surname>Sievers</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Bicarbonate-buffered ultrafiltration during pediatric cardiac surgery prevents electrolyte and acid-base balance disturbances</article-title>. <source>Perfusion</source> <year>2009</year>; <volume>24</volume>: <fpage>19</fpage>–<lpage>25</lpage></citation>
</ref>
<ref id="bibr12-0267659111424637">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dorman</surname><given-names>H</given-names></name>
<name><surname>Sade</surname><given-names>R</given-names></name>
<name><surname>Burnette</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects</article-title>. <source>Am Heart J</source> <year>2000</year>; <volume>139</volume>: <fpage>522</fpage>–<lpage>528</lpage></citation>
</ref>
<ref id="bibr13-0267659111424637">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manrique</surname><given-names>A</given-names></name>
<name><surname>Arroyo</surname><given-names>M</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Magnesium supplementation during cardiopulmonary bypass to prevent junctional ectopic tachycardia after pediatric cardiac surgery: a randomized controlled study</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>2010</year>; <volume>139</volume>: <fpage>162</fpage>–<lpage>169</lpage></citation>
</ref>
<ref id="bibr14-0267659111424637">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jian</surname><given-names>W</given-names></name>
<name><surname>Su</surname><given-names>L</given-names></name>
<name><surname>Yiwu</surname><given-names>L</given-names></name>
</person-group>. <article-title>The effects of magnesium prime solution on magnesium levels and potassium loss in open heart surgery</article-title>. <source>Anesth Analg</source> <year>2003</year>; <volume>96</volume>: <fpage>1617</fpage>–<lpage>1620</lpage></citation>
</ref>
</ref-list>
</back>
</article>